News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Round C financing of €10 million with new and existing investors
02-Jul-2014 - to-BBB announced the successful finalization of a round C financing of €10 million with new and existing investors. The company also announced the appointment of Dr. Pericles (Perry) Calias as Senior Vice President Translational Medicine and the appointment of Leonard Kruimer as interim CEO to ...
12-Sep-2013 - to-BBB announced the addition of Dr. Peter Høngaard Andersento its SupervisoryBoard. Dr. Andersen brings many years of pharma drug development experience tothe Board. Hisexperience and strategic guidance will be instrumental tofurther build to-BBB as a leading company in brain ...
14-Jan-2013 - TheALS Therapy Development Institute(ALS TDI)announcedthat it has entered into a new collaboration withto-BBBto investigate potential treatments for ALS (aka Motor Neuron or LouGehrig’sdisease). The blood-brain barrier (BBB) fortifies thewalls of blood vessels to prevent the entry of ...
03-Dec-2012 - to-BBB has been awarded the 2012 European CNS Targeted Drug Delivery Technology Innovation Award by Frost & Sullivan that is based on extensive research carried out by a team of healthcare analysts.CNS disorders are a major cause of mortality and debilitation. With increasing prevalence of ...
05-Sep-2012 - to-BBB has been awarded funding of EUR 1.25 million by the European Commission’s 7th Framework Programme as part of a EUR 5 million consortium project for the preclinical development of novel treatments for inherited retinal degenerative diseases. The consortium additionally consists of ...
24-Apr-2012 - to-BBB has been awarded funding by The Michael J. Fox Foundation (MJFF) to conduct preclinical research targeting neuroinflammation in Parkinson’s disease (PD) with its second product in development, 2B3-201. This is to-BBB’s first grant from MJFF.“We strongly believe that we can create better ...
22-Dec-2011 - to-BBB has been awarded a grant of over €600,000 through the “Internationaal Innoveren” program of the Dutch government agency Agentschap NL to support a brain drug delivery partnership with a top-5 pharma company. This work will facilitate future license deals with to-BBB’s brain cancer product ...
04-Oct-2011 - NeuroVive Pharmaceutical AB and to-BBB have been awarded a grant of €1 million through the Eureka Eurostars program for the joint development of therapies for stroke and other acute neurological conditions.The Eurostars program has awarded NeuroVive Pharmaceutical and to-BBB technologies, a grant ...
29-Jun-2011 - to-BBB announced that it has received approval to start treating patients with brain metastases with its lead product 2B3-101 in a Phase I/II clinical trial.Based on its proprietary G-Technology®, to-BBB is developing its lead compound 2B3-101, brain-targeted doxorubicin liposomes. These ...
04-Apr-2011 - to-BBB is getting ready to point its brain-targeting platform to patients with brain cancer. The Dutch Ministry of Economic Affairs, Agriculture and Innovation (Agentschap NL) supports to-BBB in this challenge by granting an “Innovation Credit”, covering 35% of the costs needed for clinical ...
© 1997-2024 LUMITOS AG, All rights reserved